SLV Selvita S.A.

4.032USD16.22 PLN · GPW-2.64%Mkt Cap: 74.00M USDP/E: —

Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design,…

Key Statistics

Company
Market Cap74.00M USD
Enterprise Value112.55M USD
Revenue (TTM)86.76M USD
Gross Profit72.93M USD
Net Income (TTM)202.12K USD
Revenue/Share4.75 USD
Last Price4.032 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees899
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLSLVCR00029
Valuation
P/E (Trailing)—
P/E (Forward)21.72
PEG—
EV/EBITDA11.83
EV/Revenue1.30
P/S0.85
P/B0.94
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
3.8532% of range12.28
52W High12.28 USD
52W Low3.853 USD
Profitability
Gross Margin80.55%
Oper. Margin2.35%
EBITDA Margin10.97%
Profit Margin0.22%
ROE0.25%
ROA0.14%
ROIC1.34%
ROCE2.63%
Growth
Revenue Growth-10.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.21M USD
CapEx (TTM)1.78M USD
FCF Margin11.24%
FCF Yield13.18%
Net Debt38.54M USD
Net Debt/EBITDA4.05
Net Debt/FCF3.95
Balance Sheet
Debt/Equity0.53
Current Ratio0.95
Quick Ratio0.81
Book Value/Sh4.27 USD
Cash/Share0.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.913 USD
Upside (mean)+121.0%
Target Range6.215 USD – 11.71 USD
6.215+121.0% to mean11.71
# Analysts6
Ownership
Shares Out.18.35M
Float9.75M
Insiders21.18%
Institutions27.31%
Technical
SMA 505.063 (-20.3%)
SMA 2007.399 (-45.5%)
Beta0.21
S&P 52W Chg12.00%
Avg Vol (30d)47.36K
Avg Vol (10d)31.98K
Technical Indicators
RSI (14)34.3
MACD-0.9223
MACD Signal-1.1430
MACD Hist.+0.2207
BB Upper4.556 USD
BB Middle4.209 USD
BB Lower3.862 USD
BB Width16.48%
ATR (14)0.2091 USD
Vol Ratio (20d)0.37x

About Selvita (WSE: SLV)

›

Selvita (WSE: SLV) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 899 employees.

The shares were at 16.22 PLN on 19 November 2026, down 60.2% over 52 weeks. Its 52-week range is 15.50 PLN to 49.40 PLN: the price is 67.2% below the high and 4.6% above the low.

Its market capitalisation is 297.66M PLN.

Selvita reports return on equity of 0.3%, an operating margin of 2.4% and revenue down 10.9% year over year.

Its debt exceeds its cash by 155.02M PLN, a debt-to-equity ratio of 0.53. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 6 analysts cover the stock; their mean price target of 35.85 PLN is 121.0% above the current price.